Long‐term glycaemic improvement after addition of metformin to insulin in insulin‐treated obese type 2 diabetes patients

Abstract

Addition of metformin to insulin induced and maintained clinically significant and consistent long-term reduction of hyperglycaemia in obese, insulin-treated type 2 diabetes patients.